Vertex Pharmaceuticals Inc. sell Robert W. Baird
Start price
31.01.24
/
50%
€400.05
Target price
31.01.25
€299.00
Performance (%)
10.29%
End price
01.02.25
€441.20
Summary
This prediction ended on 01.02.25 with a price of €441.20. The SELL prediction by Robert_W__Baird finished with a performance of 10.29%. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | -1.643% | -1.643% | -12.348% |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % |
Comments by Robert_W__Baird for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Robert_W__Baird gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was downgraded by analysts at Robert W. Baird from a "neutral" rating to an "underperform" rating. They now have a $325.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat